Information:
Error:
Keywords
Adverse event ×
- Clinical Trial (792)
- Clinical Trial, Phase III (128)
- Concomitant Medication (124)
- Vaccination (102)
- Hepatitis B (71)
- Signs and Symptoms (70)
- Vaccines (67)
- Neurology (65)
- Drug-Related Side Effects and Adverse Reactions (61)
- Hepatitis B Vaccines (59)
- Laboratories (57)
- Breast Neoplasms (53)
- Clinical Trial, Phase I (47)
- Restless Legs Syndrome (46)
- Haemophilus influenzae type b (46)
- Vital Signs (45)
- Clinical Trial, Phase II (43)
- Liver (42)
- Drug trial (41)
- Parkinsons Disease (41)
- Pharmacokinetics (37)
- Gastroenterology (37)
- Hepatitis A Vaccines (35)
- Physical Examination (33)
- On-Study Form (32)
- Hematology (32)
- Meningococcal Vaccines (27)
- Diabetes Mellitus, Type 2 (26)
- Hepatitis A (26)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (25)
- Eligibility Determination (25)
- Follow-Up Studies (23)
- Migraine Disorders (22)
- Hypereosinophilic Syndrome (21)
- Pulmonary Disease, Chronic Obstructive (21)
- Asthma (20)
- End of Study (20)
- Drugs, Investigational (19)
- Medical History Taking (19)
- Medical Records (19)
- Respiratory Insufficiency (18)
- Safety (18)
- Traumatology (18)
- Clinical Trial, Phase IV (18)
- Medical Oncology (18)
- Multiple Myeloma (18)
- Neisseria meningitidis (18)
- Colorectal Neoplasms (17)
- Classification (17)
- Pulmonary Medicine (16)
- Measles-Mumps-Rubella Vaccine (16)
- Electrocardiogram (ECG) (16)
- Demography (16)
- Gynecology (16)
- Malaria Vaccines (15)
- Alzheimer Disease (15)
- Influenza Vaccines (15)
- Cardiology (14)
- Comparative Study (14)
- Pneumococcal Vaccines (13)
- Child (13)
- Compliance (13)
- Coronary Disease (13)
- Meningitis, Meningococcal (13)
- Diphtheria-Tetanus-Pertussis Vaccine (12)
- Urinalysis (12)
- Sumatriptan (12)
- Depressive Disorder (12)
- Fever (12)
- Leukemia (12)
- Prostatic Neoplasms (11)
- Psychiatry (11)
- Scores & Instruments (11)
- Contraceptives, Oral, Combined (11)
- Diagnostic Imaging (11)
- Pharmaceutical Preparations (11)
- Hepatitis (11)
- HIV (11)
- Lung Neoplasms (11)
- Ophthalmology (11)
- Tetanus (10)
- Chickenpox Vaccine (10)
- Released Standard (10)
- Diphtheria (10)
- Informed Consent (10)
- Liver Diseases (10)
- Parkinson Disease (10)
- Schizophrenia (9)
- Biopsy (9)
- Communicable Diseases (9)
- Alcohol Drinking (9)
- Exanthema (9)
- Malaria (9)
- HIV Infections (8)
- Substance-Related Disorders (8)
- Endpoint Determination (8)
- Poliomyelitis (7)
- Pregnancy (7)
- Whooping Cough (7)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
953 Search results.
Itemgroups: Allgemeines,Grund dieser Visite bzw. dieses Kontaktes (Mehrfachauswahl),Ist seit der letzten Dokumentation für REGIMS (o. REGIMS-Visite)...,Eigene Bemerkungen / Klinischer Verlauf / Kommentar
Baseline Pregnancy Part 1
5 itemgroups 24 itemsFollow Up Pregnancy Part 1
5 itemgroups 24 itemsFollow Up Medication Change
3 itemgroups 11 items Itemgroups: Follow-up(auszufüllen nach 1, 2 und 3 Jahren),Überlebensstatus des Empfängers
Itemgroups: Mandatory Adverse Event Questions,Conditional Adverse Event Questions,Optional Adverse Event Questions,Optional Serious Adverse Event Questions
Itemgroups: General information,Details Adverse Event
Itemgroups: Header,Adverse event
Itemgroups: SUE,Patientenangaben,SUE: Beschreibung,SUE: Behandlung,SUE: Ausgang,SUE: MS-Medikation,SUE: Begleitmedikation,SUE: Relevante Vorerkrankung / Sypmtome,Ergebnisse der relevanten Diagnostischen Untersuchungen,Kontaktdaten des Berichterstatters
Itemgroups: Date of visit, Assessment Date,Adverse Event; Concomitant Agent; Evaluation, Repeat,Liver, Adverse Event,Non-serious Adverse Event,Serious Adverse Event,Concomitant Agent,Laboratory Procedures,Urinalysis,Vital signs,12 lead ECG,12 lead ECG, Abnormality, Repeat,Pharmacokinetic aspect, Blood, Repeat
Itemgroups: Investigator section,CEC Section,CEC Status
Itemgroups: Administration,Demographic Details,Volunteer Inclusion Criteria,Volunteer Exclusion Criteria,Infusion Details,ECG-Arrhythmia,Electrocardiography,Electrocardiography,Alcohol Screening (Blow test),Drug Screening (Urine),Baseline Events,Baseline Events,Adverse Events,Adverse Events
Itemgroups: Date of visit, Assessment Date,Adverse Event; Concomitant Agent; Evaluation, Repeat,Liver, Adverse Event,Non-serious Adverse Event,Serious Adverse Event,Concomitant Agent,Laboratory Procedures,Vital signs,Pharmacokinetic aspect, Blood, Repeat,Pulmonary function tests, Repeat,Holter Electrocardiography, Repeat,Holter Electrocardiography, Abnormality, Repeat,Telemetry, Repeat,Telemetry, Abnormality, Repeat,12 lead ECG, Abnormality, Repeat,12 lead ECG
Itemgroups: Note,Inclusion Criteria,Exclusion Criteria,Physical examination,Pregnancy test,Alcohol test,Urine drug screening,orthostatic blood pressure / Pulse - Predose,Concomitant medication,Adverse event,Patient diary,Randomization,High fat breakfast,Study Drug Dosing,Orthostatic blood pressure / pulse measurement - post dose,Adverse Event - post dosing,Pharmacokinetic sampling post dosing,Discharge
Itemgroups: Administration,Demographics,Serious Adverse Events,Laboratory Tests,Serology Conclusion of the Blood Sampling Timepoint Year 13